Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for strong binding interactions with biological targets due to the electron-withdrawing trifluoromethyl group and the rigid isoxazole ring. Commonly employed in medicinal chemistry to optimize drug potency and metabolic stability. Also utilized in the preparation of covalent inhibitors where the benzoic acid moiety facilitates conjugation or salt formation for improved solubility.